|
CN100389752C
(zh)
*
|
1978-04-21 |
2008-05-28 |
莱博法姆公司 |
控释组合物
|
|
CA1319144C
(en)
|
1986-11-14 |
1993-06-15 |
Quirico Branca |
Tetrahydronaphthalene derivatives
|
|
AU2436792A
(en)
|
1991-08-16 |
1993-03-16 |
Merck & Co., Inc. |
Quinazoline derivatives as inhibitors of hiv reverse transcriptase
|
|
ATE267207T1
(de)
|
1996-02-14 |
2004-06-15 |
Isis Pharmaceuticals Inc |
Kohlenhydratmodifizierte luckenhafte oligonukleotide
|
|
WO2001062740A1
(en)
|
2000-02-25 |
2001-08-30 |
South Alabama Medical Science Foundation |
Mibefradil analogues and their use
|
|
US7112319B2
(en)
|
2001-04-06 |
2006-09-26 |
The Research Foundation Of The City University Of New York |
Identification, diagnosis, and treatment of neuropathologies, neurotoxicities, tumors, and brain and spinal cord injuries using microelectrodes with microvoltammetry
|
|
AU2003237616B2
(en)
|
2002-01-17 |
2007-07-05 |
The University Of British Columbia |
Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
|
|
US7347101B2
(en)
|
2002-07-01 |
2008-03-25 |
University Of Manitoba |
Measuring strain in a structure using a sensor having an electromagnetic resonator
|
|
WO2004035000A2
(en)
|
2002-10-17 |
2004-04-29 |
Merck & Co., Inc. |
Enhancement of sleep with t-type calcium channel antagonists
|
|
US8487002B2
(en)
|
2002-10-25 |
2013-07-16 |
Paladin Labs Inc. |
Controlled-release compositions
|
|
DE602004003172T2
(de)
*
|
2003-03-21 |
2007-09-27 |
Dynogen Pharmaceuticals Inc., Waltham |
Verfahren zur behandlung von erkrankungen der unteren harnwege mit antimuskarinika und mit modulatoren der alpha-2-delta untereinheit des kalziumkanals
|
|
US7166603B2
(en)
|
2003-07-23 |
2007-01-23 |
Bristol-Myers Squibb Co. |
Dihydropyrimidone inhibitors of calcium channel function
|
|
WO2005007124A2
(en)
|
2003-07-23 |
2005-01-27 |
Bristol-Myers Squibb Company |
Substituted dihydropyrimidine inhibitors of calcium channel function
|
|
KR100610731B1
(ko)
|
2004-02-24 |
2006-08-09 |
한국과학기술연구원 |
Ｔ-형 칼슘 채널 차단제로서 유용한 ３,４-디히드로퀴나졸린유도체 및 그의 제조 방법
|
|
US7504431B2
(en)
|
2004-04-16 |
2009-03-17 |
Bristol-Myers Squibb Company |
Sulfonyl amide inhibitors of calcium channel function
|
|
JP4927735B2
(ja)
|
2004-08-20 |
2012-05-09 |
ユニバーシテイ・オブ・バージニア・パテント・フアウンデーシヨン |
Ｔ型カルシウムチャネル阻害剤
|
|
CA2576186A1
(en)
|
2004-08-20 |
2006-03-02 |
University Of Virginia Patent Foundation |
T type calcium channel blockers and the treatment of diseases
|
|
CA2600868A1
(en)
|
2005-03-09 |
2006-09-21 |
Merck & Co., Inc. |
Quinazolinone t-type calcium channel antagonists
|
|
US20100222387A1
(en)
|
2005-06-23 |
2010-09-02 |
Barrow James C |
3-Fluoro-Piperidine T-Type Calcium Channel Antagonists
|
|
CA2611639A1
(en)
|
2005-06-29 |
2007-01-04 |
Merck & Co., Inc. |
4-fluoro-piperidine t-type calcium channel antagonists
|
|
WO2007007852A1
(ja)
|
2005-07-14 |
2007-01-18 |
Teijin Chemicals Ltd. |
発泡樹脂シートおよび液晶表示装置
|
|
KR100654328B1
(ko)
|
2005-08-26 |
2006-12-08 |
한국과학기술연구원 |
피페라지닐알킬피라졸계 ｔ-타입 칼슘 채널 억제 화합물 및이의 제조방법
|
|
CA2634147A1
(en)
|
2005-12-22 |
2007-06-28 |
Icagen, Inc. |
Calcium channel antagonists
|
|
MX2008013238A
(es)
|
2006-04-12 |
2008-10-21 |
Merck & Co Inc |
Antagonistas de los canales de calcio de tipo t de piridil amida.
|
|
KR100743255B1
(ko)
|
2006-05-04 |
2007-07-27 |
한국과학기술연구원 |
Ｔ-형 칼슘 채널에 활성을 지닌 신규1,3-다이옥소아이소인돌 유도체
|
|
KR100749843B1
(ko)
|
2006-07-13 |
2007-08-21 |
한국과학기술연구원 |
Ｔ-타입 칼슘 채널에 억제 활성을 지닌 신규2,4-디옥소-퀴나졸린 유도체 및 이의 제조방법
|
|
KR100969686B1
(ko)
|
2006-08-07 |
2010-07-14 |
한국과학기술연구원 |
신규한 티아졸계 화합물 및 이를 함유하는 ｔ-형 칼슘 채널저해제
|
|
CN101534818A
(zh)
|
2006-09-15 |
2009-09-16 |
先灵公司 |
用于治疗疼痛和脂类代谢疾病的氮杂环丁烷和氮杂环丁酮衍生物
|
|
AR062790A1
(es)
|
2006-09-15 |
2008-12-03 |
Schering Corp |
Derivados de azetidina utiles en el tratamiento del dolor, diabetes y trastornos del metabolismo de los lipidos
|
|
CN101528227A
(zh)
|
2006-09-15 |
2009-09-09 |
先灵公司 |
氮杂环丁酮衍生物及其使用方法
|
|
AU2007294763A1
(en)
|
2006-09-15 |
2008-03-20 |
Schering Corporation |
Treating pain, diabetes, and lipid metabolism disorders
|
|
WO2008033464A2
(en)
|
2006-09-15 |
2008-03-20 |
Schering Corporation |
Azetidinone derivatives for the treatment of disorders of the lipid metabolism
|
|
WO2008050200A1
(en)
|
2006-10-24 |
2008-05-02 |
Pfizer Products Inc. |
Oxadiazole compounds as calcium channel antagonists
|
|
US8586619B2
(en)
|
2007-03-12 |
2013-11-19 |
Vm Therapeutics Llc |
Agents of calcium ion channel modulators
|
|
US20080227823A1
(en)
|
2007-03-12 |
2008-09-18 |
Hassan Pajouhesh |
Amide derivatives as calcium channel blockers
|
|
WO2008117148A1
(en)
|
2007-03-23 |
2008-10-02 |
Pfizer Products Inc. |
Substituted oxadiazole analogs as calcium channel antagonists
|
|
WO2008138126A1
(en)
|
2007-05-09 |
2008-11-20 |
Neuromed Pharmaceuticals Ltd. |
Bicyclic pyrimidine derivatives as calcium channel blockers
|
|
KR100863239B1
(ko)
|
2007-05-23 |
2008-10-15 |
한국과학기술연구원 |
신규한 2-이미노-1,3-티아졸린계 화합물 및 이를 함유하는ｔ-형 칼슘 채널 저해제
|
|
EP2175725A1
(en)
|
2007-07-10 |
2010-04-21 |
Merck Sharp & Dohme Corp. |
Quinazolinone t-type calcium channel antagonists
|
|
KR101079459B1
(ko)
|
2007-09-14 |
2011-11-03 |
이화여자대학교 산학협력단 |
신규한 화합물, 이의 제조방법 및 이를 포함하는 통증억제용 조성물
|
|
CN101910133A
(zh)
|
2007-10-24 |
2010-12-08 |
默沙东公司 |
杂环苯基酰胺t-型钙通道拮抗剂
|
|
EP2211864A1
(en)
|
2007-10-24 |
2010-08-04 |
Merck Sharp & Dohme Corp. |
Pyrazinyl amide t-type calcium channel antagonists
|
|
JP2011500808A
(ja)
|
2007-10-24 |
2011-01-06 |
メルク・シャープ・エンド・ドーム・コーポレイション |
複素環アミドｔ型カルシウムチャネルアンタゴニスト
|
|
WO2009056934A1
(en)
|
2007-10-31 |
2009-05-07 |
Pfizer Products Inc. |
1,4-dihydronaphthyridine derivatives
|
|
KR100917037B1
(ko)
|
2007-11-01 |
2009-09-10 |
한국과학기술연구원 |
피라졸릴카르복스아미도알킬피페라진 유도체 및 이의제조방법
|
|
US20090270413A1
(en)
|
2008-04-28 |
2009-10-29 |
Galemmo Jr Robert |
Di-t-butylphenyl piperazines as calcium channel blockers
|
|
EP3560496A1
(en)
|
2008-04-29 |
2019-10-30 |
Pharnext |
Combination compositions for treating alzheimer disease and related disorders with zonisamide and acamprosate
|
|
US20090298834A1
(en)
|
2008-06-02 |
2009-12-03 |
Hassan Pajouhesh |
4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers
|
|
US8377968B2
(en)
|
2008-06-02 |
2013-02-19 |
Zalicus Pharmaceuticals, Ltd. |
N-piperidinyl acetamide derivatives as calcium channel blockers
|
|
KR101014887B1
(ko)
|
2008-06-26 |
2011-02-15 |
한국과학기술연구원 |
칼슘이온 채널 조절제로서 유효한 이미다졸릴알킬카르보닐유도체 및 그의 제조방법
|
|
KR20100005476A
(ko)
|
2008-07-07 |
2010-01-15 |
한국과학기술연구원 |
Ｔ-형 칼슘 채널에 활성을 지닌 신규 아이소인돌리논유도체 및 이의 제조방법
|
|
US20100137403A1
(en)
|
2008-07-10 |
2010-06-03 |
Scott Malstrom |
Method for enhancing cognition or inhibiting cognitive decline
|
|
KR101052620B1
(ko)
|
2008-08-28 |
2011-07-29 |
한국과학기술연구원 |
신규 페닐아세테이트 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 ｔ-형 칼슘 이온 채널의 활성에 의해 유발되는 질환의 예방 또는 치료용 조성물
|
|
KR101052065B1
(ko)
|
2008-10-15 |
2011-07-27 |
한국과학기술연구원 |
칼슘이온 채널 조절제로서 유효한 피라졸릴메틸아민-피페라진 유도체와 이의 제조방법
|
|
TW201028421A
(en)
|
2009-01-15 |
2010-08-01 |
Abbott Lab |
Novel benzenesulfonamides as calcium channel blockers
|
|
KR20120030112A
(ko)
|
2009-06-05 |
2012-03-27 |
타우 쎄라퓨틱스 엘엘씨 |
암 또는 전암성 질환을 치료하기 위한 인터레이스 방법
|
|
EP2476308A2
(en)
|
2009-08-12 |
2012-07-18 |
Carlos Alberto Barcelo Rojas |
Bioelectronic system
|
|
JP5846372B2
(ja)
|
2010-01-29 |
2016-01-20 |
国立大学法人 岡山大学 |
Ｄｒａｖｅｔ症候群の発症可能性の判定方法およびその利用
|
|
US8575361B2
(en)
|
2010-03-02 |
2013-11-05 |
Concert Pharmaceuticals Inc. |
Tetrahydronaphthalene derivatives
|
|
KR20130139896A
(ko)
|
2010-09-08 |
2013-12-23 |
프로노바 바이오파마 너지 에이에스 |
유리산 형태의 epa 및 dha, 계면활성제, 및 스타틴을 포함하는 조성물
|
|
WO2012094615A2
(en)
|
2011-01-07 |
2012-07-12 |
Zenyaku Kogyo Kabushikikaisha |
Use of cav3.1 selective t-type calcium channel antagonists
|
|
MX2014013599A
(es)
|
2012-05-08 |
2015-05-11 |
Zafgen Inc |
Tratamiento de la obesidad hipotalamica con inhibidores de metap2.
|
|
SG11201505206WA
(en)
|
2013-01-10 |
2015-07-30 |
Tau Therapeutics Llc |
T-type calcium channel inhibitors for treatment of cancer
|
|
US10292989B2
(en)
|
2014-03-28 |
2019-05-21 |
University Of Virginia Patent Foundation |
General anesthetics that are not neurotoxic
|
|
JP2018520112A
(ja)
*
|
2015-05-26 |
2018-07-26 |
オディディ，イサ |
制御持続放出プレガバリン
|
|
KR101679262B1
(ko)
|
2015-06-08 |
2016-11-24 |
한국과학기술연구원 |
4-이소프로필크로만-3-올 화합물
|
|
GB2539472A
(en)
|
2015-06-17 |
2016-12-21 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
US9351968B1
(en)
|
2015-09-09 |
2016-05-31 |
Ovid Therapeutics Inc |
Methods of treating developmental disorders using pipradrol
|
|
US9634019B1
(en)
|
2015-10-01 |
2017-04-25 |
Silicon Storage Technology, Inc. |
Non-volatile split gate memory cells with integrated high K metal gate, and method of making same
|
|
JP6957460B2
(ja)
|
2015-10-22 |
2021-11-02 |
カビオン・インコーポレイテッドＣａｖｉｏｎ， Ｉｎｃ． |
アンジェルマン症候群および関連する障害の処置方法
|
|
MA43532A
(fr)
|
2015-12-30 |
2018-11-07 |
Adamas Pharmaceuticals Inc |
Méthodes et compositions destinés au traitement de troubles liés à des crises épileptiques
|
|
JP7321097B2
(ja)
|
2017-04-26 |
2023-08-04 |
カビオン・インコーポレイテッド |
記憶および認知を改善する、ならびに記憶および認知障害を処置するための方法
|
|
JP7326159B2
(ja)
|
2017-04-26 |
2023-08-15 |
カビオン・インコーポレイテッド |
ドラベ症候群の処置方法
|
|
GB2571978A
(en)
|
2018-03-15 |
2019-09-18 |
Andre Fisahn |
Uses, compositions and methods
|
|
IL300798B2
(en)
|
2018-10-03 |
2025-09-01 |
Cavion Inc |
Treatment of skeletal tremor with (r)–2-(4–isopropylphenyl)–n-(1-(5-(2,2,2–trifluoroethoxy)pyridin-2-yl)ethyl)acetamide
|
|
CN114340670B
(zh)
*
|
2019-07-11 |
2026-02-17 |
普拉克西斯精密药物股份有限公司 |
T-型钙通道调节剂的制剂及其使用方法
|
|
TWI870475B
(zh)
|
2019-10-02 |
2025-01-21 |
美商卡凡恩公司 |
用於治療神經毒性之方法及材料
|